2023
DOI: 10.1021/acsmedchemlett.3c00234
|View full text |Cite
|
Sign up to set email alerts
|

Novel Dihydroorotate Dehydrogenase Inhibitors for Treating Acute Myelogenous Leukemia

Abstract: Provided herein are novel dihydroortate dehydrogenase (DHODH) inhibitors, pharmaceutical compositions, use of such compounds in treating acute myelogenous leukemia (AML), and processes for preparing such compounds.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 6 publications
0
0
0
Order By: Relevance